实验美控 LH 深 沪
交易中 02-03 10:51:51 美东时间
273.61
+3.320
+1.23%
华盛通- 最 高275.49
- 今 开269.28
- 成交量 3.39万股
- 最 低 269.28
- 昨 收 270.29
- 总市值 226.82亿
- 52周最高 293.00
- 市盈率 静 30.96
- 换手率 0.04%
- 52周最低 207.215
- 委 比 -50.00%
- 总股本 8290.00万
- 历史最高 293.00
- 量 比 0.28
- 振 幅 2.30%
- 历史最低 29.76
- 每 手 1
- 风险率 16.34%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Labcorp Extends Receivables Facility to 2029 and Adds $125 Million Accordion Option
Labcorp Extends Receivables Facility to 2029 and Adds $125 Million Accordion Option Labcorp Holdings Inc. has amended its existing receivables purchase agreement by entering into a Second Amendment with Labcorp Receivables LLC, PNC Bank, National Association, and other parties. Key changes include e
01-30 05:17
Labcorp Holdings declares $0.72 dividend
Labcorp Holdings (LH) declared $0.72/share quarterly dividend, in line with previous. Forward yield 1.13% Payable March 12; for shareholders of record Feb. 27; ex-div Feb. 27. See LH Dividend Scorecar...
01-14 20:17
Labcorp Declares Quarterly Dividend
BURLINGTON, N.C., Jan. 14, 2026 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Direc...
01-14 19:50
NAMSA Acquires Labcorp's Early Development Medical Device Testing Operations; Financial Terms Not Disclosed
NAMSA, a global leader in medical device testing, clinical research, and regulatory consulting, is pleased to announce it has completed the acquisition of the Early Development medical device testing business
01-08 21:38
Labcorp Appoints Victor Bulto to Board of Directors
Bulto, President, U.S. of Novartis, brings global healthcare leadership and growth track record to support Labcorp's long-term strategy BURLINGTON, N.C., Nov. 24, 2025 /PRNewswire/ -- Labcor...
2025-11-24 21:30
New Studies Highlight Labcorp Plasma Detect's Role in Early Cancer Detection and Post-Surgery Monitoring
Labcorp (NYSE:LH), a global leader of innovative and comprehensive laboratory services, today announced Labcorp Plasma Detect, a tumor-informed, blood-based assay used to detect molecular residual disease
2025-11-19 20:10
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 17:17
美股大行评级 | 潜在涨幅1307.13%！HC Wainwright & Co.：Adicet Bio获机构升目标价至9美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Adicet Bio"买入"评级，目标价从4美元升至9美元；Citizens: 维持Rapport Therapeutics"跑赢大市"评级，目标价从77美元升至80美元
2025-11-10 10:22
JP Morgan Maintains Overweight on Labcorp Hldgs, Raises Price Target to $317
JP Morgan analyst Lisa Gill maintains Labcorp Hldgs (NYSE:LH) with a Overweight and raises the price target from $291 to $317.
2025-11-08 03:55
